The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1

AIDS. 2018 Jan 28;32(3):404-406. doi: 10.1097/QAD.0000000000001719.

Authors

Christopher J A Duncan^{1

2}, Fraser G Charlton³, Mark Bower⁴, David A Price¹

Affiliations

¹ Department of Infectious Diseases and Tropical Medicine, Royal Victoria Infirmary.
² Inflammation, Immunology and Immunotherapy Theme, Institute of Cellular Medicine, Medical School, Newcastle University.
³ Department of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne.
⁴ Director, National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK.

PMID: 29309348
DOI: 10.1097/QAD.0000000000001719

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

AIDS-Associated Nephropathy / diagnosis*
AIDS-Associated Nephropathy / pathology
Acquired Immunodeficiency Syndrome / complications*
Acquired Immunodeficiency Syndrome / drug therapy
Anti-Retroviral Agents / therapeutic use
Antineoplastic Agents / therapeutic use
Biopsy
Herpesvirus 8, Human / isolation & purification*
Histocytochemistry
Homosexuality, Male
Humans
Lymphoma, Primary Effusion / diagnosis*
Lymphoma, Primary Effusion / pathology
Male
Microscopy
Middle Aged
Sarcoma, Kaposi / diagnosis*
Sarcoma, Kaposi / pathology
Treatment Outcome

Substances

Anti-Retroviral Agents
Antineoplastic Agents